Staphylococcus aureus infections remain a formidable health threat, responsible for the most infection-related deaths ...

A one-time gene therapy using a patient’s own stem cells has effectively cured a deadly immune disorder in 95% of treated ...

Scientists at St. Jude Children’s Research Hospital have demonstrated how the ASPL protein moonlights to both form and ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

The neurodegenerative disease damages patients’ motor, cognitive and behavioral controls, which sometimes manifest as ...

Dr. Toma Omofoye says she focuses on being the “best early detector” of breast cancer she can be. As a breast imaging radiologist at the University of Texas MD Anderson Cancer Center in Houston, she ...

Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But last ...

There are three main subtypes and they’re grouped by three genetic markers your doctor will look for on a biopsy specimen: the estrogen receptor, progesterone receptor, and a protein called HER2, ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal neurodegenerative condition. Scientists from University College London (UCL) found patients ...

AUSTIN (KXAN) — An exceptionally rare and fatal genetic disease may finally have a solution. Huntington’s Disease affects one in ten to twenty thousand Americans. The disease is a mixture of dementia ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...